Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Moelcules in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market

Report Summary

GBI Research, the leading business intelligence provider, has released its latest research, “Emerging Cancer Vaccines Market to 2017”, which provides insights into global emerging cancer vaccines market and market forecast until 2017. The report provides an in-depth analysis of the five therapeutic indications for which vaccines are available in the market or has a promising vaccine in phase III of their pipeline. In addition, the report also includes various types of cancer vaccine development and vaccine delivery methods along with a case study, advantages and disadvantages for each type; insights into the cancer vaccines R&D pipeline; SWOT profile of the vaccine companies; and major M&A, deals and co-developments.

Scope

• The scope of this report includes:
• Descriptive case study, advantages and disadvantages for various types of cancer vaccine development and vaccine delivery methods
• Data and analysis on the emerging cancer vaccines market
• Annualized market data for the cancer vaccines market with forecasts to 2017
• Market data on the therapeutic landscape which covers cervical cancer, prostate cancer, lung cancer, pancreatic cancer and melanoma, including market size, market share and annual cost of vaccination
• Key drivers and restraints that have had a significant impact on the market and on each indication
• The competitive landscape of the emerging cancer vaccines market which includes companies such as Merck, Amgen, GlaxoSmithKline, Dendreon
• Key M&A, deals and co-developments that took place from 2004 to 2011 in the global cancer vaccines market

Reasons to Buy

• The report will enhance your decision making capability. It will allow you to:
• Familiarize with different types of cancer vaccine development and vaccine delivery methods with case studies, advantages and disadvantages for a better understanding
• Align your product portfolio to the markets with high growth potential.
• Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
• Device a more tailored country strategy through the understanding of key drivers and barriers of the region’s cancer vaccines market.
• Develop key strategic initiatives by understanding the key focus areas and top selling vaccines of leading companies.
• Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

N/A